<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://business.financialpost.com/pmn/business-pmn/novartis-nears-deal-to-buy-u-s-biotech-firm-medicines-co-for-about-7-bln-wsj"/>
    <meta property="og:site_name" content="Financial Post"/>
    <meta property="article:published_time" content="2019-11-23T19:26:51+00:00"/>
    <meta property="og:title" content="Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ"/>
    <meta property="og:description" content="Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday."/>
  </head>
  <body>
    <article>
      <h1>Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ</h1>
      <address><time datetime="2019-11-23T19:26:51+00:00">23 Nov 2019, 19:26</time> by <a rel="author">Reuters</a></address>
      <p>Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported <a href="https://on.wsj.com/2qveZtj">https://on.wsj.com/2qveZtj</a> on Saturday.</p>
      <p>The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.</p>
      <p>Neither Novartis nor The Medicines Co were immediately available for comment on Saturday. (Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis)</p>
    </article>
  </body>
</html>